» Articles » PMID: 19059883

NAD(P)H Quinone Oxidoreductase 1 is Essential for Ozone-induced Oxidative Stress in Mice and Humans

Overview
Date 2008 Dec 9
PMID 19059883
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

One host susceptibility factor for ozone identified in epidemiologic studies is NAD(P)H quinone oxidoreductase 1 (NQO1). We hypothesized that after ozone exposure, NQO1 is required to increase 8-isoprostane (also known as F(2)-isoprostane) production, a recognized marker of ozone-induced oxidative stress, and to enhance airway inflammation and hyperresponsiveness. In this report, we demonstrate that in contrast to wild-type mice, NQO1-null mice are resistant to ozone and have blunted responses, including decreased production of F(2)-isoprostane and keratinocyte chemokine, decreased airway inflammation, and diminished airway hyperresponsiveness. Importantly, these results in mice correlate with in vitro findings in humans. In primary human airway epithelial cells, inhibition of NQO1 by dicumarol blocks ozone-induced F(2)-isoprostane production and IL-8 gene expression. Together, these results demonstrate that NQO1 modulates cellular redox status and influences the biologic and physiologic effects of ozone.

Citing Articles

Association Between Air Pollution and Lung Lobar Emphysema in COPD.

Thanh Tung N, Ho S, Lu Y, Chen T, Lee K, Chen K Front Med (Lausanne). 2021; 8:705792.

PMID: 34621758 PMC: 8490678. DOI: 10.3389/fmed.2021.705792.


Erratum: NAD(P)H Quinone Oxidoreductase 1 Is Essential for Ozone-Induced Oxidative Stress in Mice and Humans.

Am J Respir Cell Mol Biol. 2016; 55(6):909.

PMID: 27906558 PMC: 6835088. DOI: 10.1165/rcmb.556erratum.


Oxidative Stress and Therapeutic Development in Lung Diseases.

Villegas L, Stidham T, Nozik-Grayck E J Pulm Respir Med. 2016; 4(4).

PMID: 27019769 PMC: 4807858. DOI: 10.4172/2161-105X.1000194.


Evaluating potential response-modifying factors for associations between ozone and health outcomes: a weight-of-evidence approach.

Vinikoor-Imler L, Owens E, Nichols J, Ross M, Brown J, Sacks J Environ Health Perspect. 2014; 122(11):1166-76.

PMID: 24927060 PMC: 4216162. DOI: 10.1289/ehp.1307541.


Regulation of Wnt4 in chronic obstructive pulmonary disease.

Durham A, McLaren A, Hayes B, Caramori G, Clayton C, Barnes P FASEB J. 2013; 27(6):2367-81.

PMID: 23463699 PMC: 3659349. DOI: 10.1096/fj.12-217083.


References
1.
Janssen L, Catalli A, Helli P . The pulmonary biology of isoprostanes. Antioxid Redox Signal. 2005; 7(1-2):244-55. DOI: 10.1089/ars.2005.7.244. View

2.
Romieu I, Ramirez-Aguilar M, Sienra-Monge J, Moreno-Macias H, Del Rio-Navarro B, David G . GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J. 2006; 28(5):953-9. DOI: 10.1183/09031936.06.00114905. View

3.
Bey E, Bentle M, Reinicke K, Dong Y, Yang C, Girard L . An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci U S A. 2007; 104(28):11832-7. PMC: 1913860. DOI: 10.1073/pnas.0702176104. View

4.
Samet J, Hatch G, Horstman D, Steck-Scott S, Arab L, Bromberg P . Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med. 2001; 164(5):819-25. DOI: 10.1164/ajrccm.164.5.2008003. View

5.
Janssen L . Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol. 2001; 280(6):L1067-82. DOI: 10.1152/ajplung.2001.280.6.L1067. View